Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Hara, Kyoko ^a   Shirasuna, Koumei ^a,b   Usui, Fumitake ^a   Karasawa, Tadayoshi ^a   Mizushina, Yoshiko ^a   Kimura, Hiroaki ^a   Kawashima, Akira ^a   Ohkuchi, Akihide ^a   Matsuyama, Shuichi ^c   Kimura, Koji ^c   Takahashi, Masafumi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^c NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; NANOPARTICLE; TAU INTERFERON; ACTIN; AUTACOID; CYTOKINE; IMMUNOGLOBULIN RECEPTOR; INTERFERON; MARCO PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; SCAVENGER RECEPTOR; SILICON DIOXIDE;

ACTIN POLYMERIZATION; ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; MACROPHAGE; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BOVINE; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE SILENCING; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN MULTIMERIZATION; SECRETION (PROCESS);

ACTINS; ANIMALS; CATTLE; CELL LINE; CYTOKINES; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE I; INTERLEUKIN-1BETA; MACROPHAGES; NANOPARTICLES; PHAGOCYTOSIS; PROTEIN MULTIMERIZATION; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SILICON DIOXIDE;

EID: 84915748455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113974     Document Type: Article

References (35)

1. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264.
2. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174.
3. Inoue M, Shinohara ML (2013) The role of interferon-beta in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. Immunology 139: 11-18.
4. Imakawa K, Anthony RV, Kazemi M, Marotti KR, Polites HG, et al. (1987) Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature 330: 377-379.
5. Alexenko AP, Ealy AD, Roberts RM (1999) The cross-species antiviral activities of different IFN-tau subtypes on bovine, murine, and human cells: contradictory evidence for therapeutic potential. J Interferon Cytokine Res 19: 1335-1341.
6. Soos JM, Stuve O, Youssef S, Bravo M, Johnson HM, et al. (2002) Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J Immunol 169: 2231-2235.
7. Soos JM, Subramaniam PS, Hobeika AC, Schiffenbauer J, Johnson HM (1995) The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol 155: 2747-2753.
8. Chon TW, Bixler S (2010) Interferon-tau: current applications and potential in antiviral therapy. J Interferon Cytokine Res 30: 477-485.
9. Davis BK, Wen H, Ting JP (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-735.
10. Takahashi M (2011) Role of the inflammasome in myocardial infarction. Trends Cardiovasc Med 21: 37-41.
11. Rathinam VA, Vanaja SK, Fitzgerald KA (2012) Regulation of inflammasome signaling. Nat Immunol 13: 333-332.
12. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
13. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, et al. (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 105: 9035-9040.
14. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.
15. Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, et al. (2013) Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 18: 519-532.
16. Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, et al. (2008) Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation 117: 3079-3087.
17. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, et al. (2011) Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123: 594-604.
18. Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, et al. (2012) Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun 425: 162-168.
19. Komada T, Usui F, Shirasuna K, Kawashima A, Kimura H, et al. ASC in renal collecting duct epithelial cells contributes to inflammation and injury after unilateral ureteral obstruction. Am J Pathol 184: 1287-1298.
20. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, et al. (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213-223.
21. Inoue M, Williams KL, Oliver T, Vandenabeele P, Rajan JV, et al. (2012) Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci Signal 5: ra38.
22. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, et al. (2012) Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490: 288-291.
23. Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, et al. (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150: 606-619.
24. Rauch I, Muller M, Decker T (2013) The regulation of inflammation by interferons and their STATs. JAKSTAT 2: e23820.
25. Shirasuna K, Usui F, Karasawa T, Kimura H, Kawashima A, et al. (2014) Nanosilica-induced placental inflammation and pregnancy complications: Different roles of the inflammasome components NLRP3 and ASC. Nanotoxicology In press: 1-14.
26. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
27. Kanno S, Furuyama A, Hirano S (2007) A murine scavenger receptor MARCO recognizes polystyrene nanoparticles. Toxicol Sci 97: 398-406.
28. Takahashi M (2014) NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J 55: 101-105.
29. Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (∗). Annu Rev Immunol 27: 621-668.
30. Robertson SA, Skinner RJ, Care AS (2006) Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 177: 4888-4896.
31. Lai Z, Kalkunte S, Sharma S (2011) A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice. Hypertension 57: 505-514.
32. Mukhopadhyay S, Varin A, Chen Y, Liu B, Tryggvason K, et al. (2011) SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 117: 1319-1328.
33. Rogez-Kreuz C, Maneglier B, Martin M, Dereuddre-Bosquet N, Martal J, et al. (2005) Involvement of IL-6 in the anti-human immunodeficiency virus activity of IFN-tau in human macrophages. Int Immunol 17: 1047-1057.
34. Nakajima A, Sokawa Y (2002) Induction of blood 2′, 5′-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau. J Interferon Cytokine Res 22: 397-402.
35. Frausto-Del-Rio D, Soto-Cruz I, Garay-Canales C, Ambriz X, Soldevila G, et al. (2012) Interferon gamma induces actin polymerization, Rac1 activation and down regulates phagocytosis in human monocytic cells. Cytokine 57: 158-168.